M. Morton

Targeting the rheumatoid arthritis synovial fibroblast via cyclin dependent kinase inhibition

J. Isaacs, M. Cole, D. Stocken, 2020, Medicine.

Prostate cancer androgen receptor splice variant 7 biomarker study - a multicentre randomised feasibility trial of biomarker-guided personalised treatment in patients with advanced prostate cancer (the VARIANT trial) study protocol

D. Howel, J. Staffurth, I. Pedley, 2019, BMJ Open.

Targeting the rheumatoid arthritis synovial fibroblast via cyclin dependent kinase inhibition

J. Isaacs, M. Cole, D. Stocken, 2020, Medicine.

Using the AR-V7 biomarker to determine treatment in metastatic castrate resistant prostate cancer, a feasibility randomised control trial, conclusions from the VARIANT trial

I. Pedley, S. Crabb, E. Clark, 2022, NIHR open research.